Bringing the fundamentals into focus…
Back to Perspective Therapeutics, Inc.
How Perspective Therapeutics, Inc. stacks up
CATX · against 557 other Healthcare companies listed in US-listed
Profitability
19/ 100
Below the middle of the pack.
Ranked #345 of 558 · scores higher than 37% of peers
Bars: peers in each 10-point band of the profitability score114 peers with a profitability score of 10–19, including CATX · Click a bar to see the companies
Why profitability scores 19?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 86% of peers. Return on assets: -29.7% vs peer median 1.7%
- a lower return on invested capital: weaker than 84% of peers. Return on invested capital: -35.7% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = CATX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CATX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -35.7% | -7.0% | 30% | 33% | |
| Operating marginHigher is better · 479 reported | Not reported | -2.4% | — | — | 33% |
| Return on assetsHigher is better · 582 reported | -29.7% | -7.8% | 29% | 33% | |
| Return on equityHigher is better · 531 reported | -39.6% | -19.7% | 37% | Context only | |
| Gross marginHigher is better · 601 reported | 0.0% | 43.9% | 6% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around CATX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 335 | 299M USD | 20 | 38 | |
| 335 | 7.8B USD | 20 | 30 | |
| 335 | 646M USD | 20 | 46 | |
| 345 | 815M USD | 19 | 53 | |
| 345 | 100M USD | 19 | 37 | |
| 345 | 647M USD | 19 | 40 | |
| 345 | 441M USD | 19 | 34 | |
| 345 | 1.5B USD | 19 | 32 | |
| 345 | 758M USD | 19 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score